RECURSION PHARMACEUTICALS-A (RXRX) Stock Analyst Earnings Estimates
NASDAQ:RXRX - Nasdaq - US75629V1044 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.84M 291.36% | 44.575M 11.89% | 58.839M 32.00% | 70.582M 19.96% | 113.91M 61.39% | 216.08M 89.69% | |
| EBITDA YoY % growth | -233.97M -34.19% | -324.458M -38.68% | -442.51M -36.38% | -535.798M -21.08% | -439.375M 18.00% | -398.111M 9.39% | |
| EBIT YoY % growth | -245.73M -34.45% | -348.86M -41.97% | -479.004M -37.31% | -577.091M -20.48% | -469.366M 18.67% | -381.524M 18.72% | |
| Operating Margin | -616.79% | -782.64% | -814.09% | -817.62% | -412.05% | -176.57% | |
| EPS YoY % growth | -1.37 -12.87% | -1.57 -14.60% | -1.66 -5.73% | -1.49 10.29% | -1.19 19.86% | -0.72 39.32% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.31 7.60% | -0.30 43.80% | -0.31 38.12% |
| Revenue Q2Q % growth | 19.584M -24.91% | 23.63M 423.83% | 16.677M 13.10% |
| EBITDA Q2Q % growth | -113.22M -51.34% | -132.906M 9.76% | -104.244M 39.41% |
| EBIT Q2Q % growth | -132.995M -35.22% | -121.836M 33.70% | -127.607M 33.32% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.41 -2.50% | -0.36 | -0.05 | -14.85% |
| Q1 2025 Q2Q % growth | -0.50 -28.21% | -0.54 | 0.04 | 6.63% |
| Q4 2024 Q2Q % growth | -0.53 -26.19% | -0.44 | -0.09 | -20.37% |
| Q3 2024 Q2Q % growth | -0.34 20.93% | -0.36 | 0.02 | 4.76% |
| Q2 2024 Q2Q % growth | -0.40 -5.26% | -0.41 | 0.01 | 1.55% |
| Q1 2024 Q2Q % growth | -0.39 -14.71% | -0.43 | 0.04 | 9.68% |
| Q4 2023 Q2Q % growth | -0.42 -35.48% | -0.46 | 0.04 | 8.24% |
| Q3 2023 Q2Q % growth | -0.43 -22.86% | -0.39 | -0.04 | -9.50% |
| Q2 2023 Q2Q % growth | -0.38 | -0.38 | 0.00 | 0.47% |
| Q1 2023 Q2Q % growth | -0.34 -3.03% | -0.35 | 0.01 | 4.21% |
| Q4 2022 Q2Q % growth | -0.31 18.42% | -0.30 | -0.01 | -4.80% |
| Q3 2022 Q2Q % growth | -0.35 -25.00% | -0.39 | 0.04 | 9.10% |
| Q2 2022 Q2Q % growth | -0.38 -22.58% | -0.38 | 0.00 | 0.21% |
| Q1 2022 Q2Q % growth | -0.33 75.19% | 0.10 | -0.43 | -423.53% |
| Q4 2021 Q2Q % growth | -0.38 | -0.31 | -0.07 | -21.48% |
| Q3 2021 Q2Q % growth | -0.28 | -0.29 | 0.01 | 1.96% |
| Q2 2021 Q2Q % growth | -0.31 | -0.24 | -0.07 | -30.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 19.22M 33.31% | 15.742M | 3.478M | 22.09% |
| Q1 2025 Q2Q % growth | 14.745M 6.89% | 18.479M | -3.734M | -20.21% |
| Q4 2024 Q2Q % growth | 4.511M -58.58% | 19.424M | -14.913M | -76.78% |
| Q3 2024 Q2Q % growth | 26.082M 147.62% | 30.44M | -4.358M | -14.32% |
| Q2 2024 Q2Q % growth | 14.417M 30.86% | 13.522M | 895K | 6.62% |
| Q1 2024 Q2Q % growth | 13.794M 13.68% | 12.903M | 891K | 6.91% |
| Q4 2023 Q2Q % growth | 10.891M -20.39% | 20.76M | -9.869M | -47.54% |
| Q3 2023 Q2Q % growth | 10.533M -19.96% | 13.127M | -2.594M | -19.76% |
| Q2 2023 Q2Q % growth | 11.017M 43.64% | 12.153M | -1.136M | -9.35% |
| Q1 2023 Q2Q % growth | 12.134M 127.65% | 14.734M | -2.6M | -17.65% |
| Q4 2022 Q2Q % growth | 13.68M 440.71% | 24.48M | -10.8M | -44.12% |
| Q3 2022 Q2Q % growth | 13.16M 420.16% | 7.115M | 6.045M | 84.96% |
| Q2 2022 Q2Q % growth | 7.67M 200.78% | 5.508M | 2.162M | 39.25% |
| Q1 2022 Q2Q % growth | 5.33M 108.20% | 85.629M | -80.299M | -93.78% |
| Q4 2021 Q2Q % growth | 2.53M | 6.188M | -3.658M | -59.11% |
| Q3 2021 Q2Q % growth | 2.53M | 2.754M | -224K | -8.13% |
| Q2 2021 Q2Q % growth | 2.55M 1,242.11% | 2.78M | -230K | -8.27% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.16% | 29.29% | -0.1% | 10.51% |
| Revenue | -4.93% | -21.99% | -2.88% | -23.74% |